SEARCH

SEARCH BY CITATION

References

  • 1
    Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev2005; 18: 657686.
  • 2
    Cohen Stuart J, Diederen B, Al Naiemi N et al. A method for phenotypic detection of extended spectrum β-lactamases in Enterobacter species in the routine clinical setting. J Clin Microbiol2011; 7: 27112713.
  • 3
    Mohanty S, Gaind R, Ranjan R, Deb M. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum β-lactamases in AmpC co-producing bacteria. J Infect Dev Ctries2009; 4: 2429.
  • 4
    Sturenburg E, Sobottka I, Noor D, Laufs R, Mack D. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum β-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother2004; 54: 134138.
  • 5
    Cohen Stuart J, Dierikx C, Al Naiemi N et al. Rapid detection of TEM, SHV and CTX-M extended-spectrum β-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother2010; 65: 13771381.
  • 6
    Voets GM, Fluit AC, Scharringa J, Cohen Stuart J, Leverstein-van Hall MA. A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Int J Antimicrob Agents2011; 4: 134138.
  • 7
    Miro E, del Cuerpo M, Navarro F, Sabate M, Mirelis B, Prats G. Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction. J Antimicrob Chemother1998; 42: 535538.
  • 8
    Wiegand I, Geiss HK, Mack D, Sturenburg E, Seifert H. Detection of extended-spectrum β-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol2007; 45: 11671174.
  • 9
    Sturm PD, Bochum ET, van Mook-Vermulst SV, Handgraaf C, Klaassen T, Melchers WJ. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum β-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Microb Drug Resist2010; 16: 5560.
  • 10
    Beceiro A, Maharjan S, Gaulton T et al. False extended-spectrum β-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. J Antimicrob Chemother2011; 9: 20062010.
  • 11
    Towne TG, Lewis JS 2nd, Herrera M, Wickes B, Jorgensen JH. Detection of SHV-type extended-spectrum β-lactamase in Enterobacter isolates. J Clin Microbiol2010; 48: 298299.